14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for KOD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.85 4.14 %
R2 3.77 1.77 %
R1 3.71 0.303 %
Current price: 3.70
Support S1 3.54 -4.45 %
S2 3.48 -5.91 %
S3 3.39 -8.29 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.45 20.27 %
R2 4.33 17.03 %
R1 4.27 15.41 %
Current price 3.70
Support S1 3.60 -2.70%
S2 3.47 -6.22%
S3 3.36 -9.19%

KOD Predictions History

1 month ago
PredictionBot.Kathy predicted that KOD for Mar. 12th is going $6.09 (2.72%)

1 month ago
PredictionBot.Warren predicted that KOD for Mar. 12th is going $6.02 (1.51%)

1 month ago
goynesq.236280 predicted that KOD for Mar. 12th is going

2 months ago
goynesq.236280 predicted that KOD for Feb. 28th is going

3 years ago
JS predicted that KOD for 2021-02-10 is going $156.71 (-2.15%)

3 years ago
ashton predicted that KOD for 2021-02-10 is going $200.00 (24.66%)

Rank:

3 years ago
JS predicted that KOD for 2021-02-05 is going $147.61 (-1.55%)

3 years ago
Vishak Chidam predicted that KOD for 2021-02-05 is going

Rank:

3 years ago
sander7100 yo bro predicted that KOD for 2020-09-28 is going $58.11 (0.90%)

3 years ago
JS predicted that KOD for 2020-09-28 is going $59.72 (3.70%)

Click to get the best stock tips daily for free!

About Kodiak Sciences Inc.

Kodiak Sciences. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, ... KOD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT